Editorial: Blockade of PD‐1 and PD‐L1 restores defective innate immune responses in leukocytes from septic humans
dc.contributor.author | Ward, Peter A. | |
dc.contributor.author | Fattahi, Fatemeh | |
dc.date.accessioned | 2018-02-05T16:36:44Z | |
dc.date.available | 2018-02-05T16:36:44Z | |
dc.date.issued | 2016-12 | |
dc.identifier.citation | Ward, Peter A.; Fattahi, Fatemeh (2016). "Editorial: Blockade of PD‐1 and PD‐L1 restores defective innate immune responses in leukocytes from septic humans." Journal of Leukocyte Biology 100(6): 1229-1231. | |
dc.identifier.issn | 0741-5400 | |
dc.identifier.issn | 1938-3673 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/141591 | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.subject.other | immunosuppression | |
dc.subject.other | phagocytosis | |
dc.subject.other | sepsis | |
dc.subject.other | checkpoint proteins | |
dc.title | Editorial: Blockade of PD‐1 and PD‐L1 restores defective innate immune responses in leukocytes from septic humans | |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Microbiology and Immunology | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.contributor.affiliationum | Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/141591/1/jlb1229.pdf | |
dc.identifier.doi | 10.1189/jlb.3CE0816-360R | |
dc.identifier.source | Journal of Leukocyte Biology | |
dc.identifier.citedreference | Patera, A. C., Drewry, A. M., Chang, K., Beiter, E. R., Osborne, D., Hotchkiss, R. S. ( 2016 ) Frontline science: defects in immune function in patients with sepsis are associated with PD‐1 or PD‐L1 expression and can be restored by antibodies targeting PD‐1 or PD‐L1. J. Leukoc. Biol. 100, 1239 – 1254. | |
dc.identifier.citedreference | Wang, J. F., Li, J. B., Zhao, Y. J., Yi, W. J., Bian, J. J., Wan, X. J., Zhu, K. M., Deng, X. M. ( 2015 ) Up‐regulation of programmed cell death 1 ligand 1 on neutrophils may be involved in sepsis‐induced immunosuppression: an animal study and a prospective case‐control study. Anesthesiology 122, 852 – 863. | |
dc.identifier.citedreference | Huang, X., Chen, Y., Chung, C. S., Yuan, Z., Monaghan, S. F., Wang, F., Ayala, A. ( 2014 ) Identification of B7‐H1 as a novel mediator of the innate immune/proinflammatory response as well as a possible myeloid cell prognostic biomarker in sepsis. J. Immunol. 192, 1091 – 1099. | |
dc.identifier.citedreference | Rittirsch, D., Flierl, M. A., Ward, P. A. ( 2008 ) Harmful molecular mechanisms in sepsis. Nat. Rev. Immunol. 8, 776 – 787. | |
dc.identifier.citedreference | Martin, G. S., Mannino, D. M., Moss, M. ( 2006 ) The effect of age on the development and outcome of adult sepsis. Crit. Care Med. 34, 15 – 21. | |
dc.identifier.citedreference | Yende, S., Austin, S., Rhodes, A., Finfer, S., Opal, S., Thompson, T., Bozza, F. A., LaRosa, S. P., Ranieri, V. M., Angus, D. C. ( 2016 ) Long‐term quality of life among survivors of severe sepsis: Analyses of two international trials. Crit. Care Med. 44, 1461 – 1467. | |
dc.identifier.citedreference | Loke, P., Allison, J. P. ( 2003 ) PD‐L1 and PD‐L2 are differentially regulated by Th1 and Th2 cells. Proc. Natl. Acad. Sci. USA 100, 5336 – 5341. | |
dc.identifier.citedreference | Dong, Z. Y., Wu, S. P., Liao, R. Q., Huang, S. M., Wu, Y. L. ( 2016 ) Potential biomarker for checkpoint blockade immunotherapy and treatment strategy. Tumour Biol. 37, 4251 – 4261. | |
dc.identifier.citedreference | Patil, N. K., Bohannon, J. K., Sherwood, E. R. ( 2016 ) Immunotherapy: a promising approach to reverse sepsis‐induced immunosuppression. Pharmacol. Res. 111, 688 – 702. | |
dc.identifier.citedreference | Zelinskyy, G., Myers, L., Dietze, K. K., Gibbert, K., Roggendorf, M., Liu, J., Lu, M., Kraft, A. R., Teichgräber, V., Hasenkrug, K. J., Dittmer, U. ( 2011 ) Virus‐specific CD8+ T cells upregulate programmed death‐1 expression during acute friend retrovirus infection but are highly cytotoxic and control virus replication. J. Immunol. 187, 3730 – 3737. | |
dc.identifier.citedreference | Gandini, S., Massi, D., Mandalà, M. ( 2016 ) PD‐L1 expression in cancer patients receiving anti PD‐1/PD‐L1 antibodies: a systematic review and meta‐analysis. Crit. Rev. Oncol. Hematol. 100, 88 – 98. | |
dc.identifier.citedreference | Delano, M. J., Ward, P. A. ( 2016 ) Sepsis‐induced immune dysfunction: can immune therapies reduce mortality? J. Clin. Invest. 126, 23 – 31. | |
dc.identifier.citedreference | Minnich, D. J., Moldawer, L. L. ( 2004 ) Anti‐cytokine and anti‐inflammatory therapies for the treatment of severe sepsis: progress and pitfalls. Proc. Nutr. Soc. 63, 437 – 441. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.